vs
Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $57.3M, roughly 1.8× RHYTHM PHARMACEUTICALS, INC.). CARRIAGE SERVICES INC runs the higher net margin — 11.6% vs -83.0%, a 94.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 8.0%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 1.0%).
Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CSV vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $105.5M | $57.3M |
| Net Profit | $12.3M | $-47.5M |
| Gross Margin | 34.8% | 91.6% |
| Operating Margin | 23.3% | -82.2% |
| Net Margin | 11.6% | -83.0% |
| Revenue YoY | 8.0% | 36.9% |
| Net Profit YoY | 24.5% | -9.6% |
| EPS (diluted) | $0.76 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $105.5M | $57.3M | ||
| Q3 25 | $102.7M | $51.3M | ||
| Q2 25 | $102.1M | $48.5M | ||
| Q1 25 | $107.1M | $32.7M | ||
| Q4 24 | $97.7M | $41.8M | ||
| Q3 24 | $100.7M | $33.3M | ||
| Q2 24 | $102.3M | $29.1M | ||
| Q1 24 | $103.5M | $26.0M |
| Q4 25 | $12.3M | $-47.5M | ||
| Q3 25 | $6.6M | $-52.9M | ||
| Q2 25 | $11.7M | $-46.6M | ||
| Q1 25 | $20.9M | $-49.5M | ||
| Q4 24 | $9.9M | $-43.3M | ||
| Q3 24 | $9.9M | $-43.6M | ||
| Q2 24 | $6.3M | $-32.3M | ||
| Q1 24 | $7.0M | $-141.4M |
| Q4 25 | 34.8% | 91.6% | ||
| Q3 25 | 35.3% | 89.3% | ||
| Q2 25 | 35.2% | 88.6% | ||
| Q1 25 | 35.3% | 88.8% | ||
| Q4 24 | 34.4% | 90.9% | ||
| Q3 24 | 35.2% | 88.5% | ||
| Q2 24 | 36.2% | 89.9% | ||
| Q1 24 | 36.0% | 89.2% |
| Q4 25 | 23.3% | -82.2% | ||
| Q3 25 | 17.0% | -102.6% | ||
| Q2 25 | 23.5% | -93.4% | ||
| Q1 25 | 29.5% | -143.7% | ||
| Q4 24 | 21.6% | -98.6% | ||
| Q3 24 | 22.7% | -132.0% | ||
| Q2 24 | 18.0% | -139.2% | ||
| Q1 24 | 18.8% | -538.7% |
| Q4 25 | 11.6% | -83.0% | ||
| Q3 25 | 6.4% | -103.1% | ||
| Q2 25 | 11.5% | -96.1% | ||
| Q1 25 | 19.5% | -151.4% | ||
| Q4 24 | 10.1% | -103.6% | ||
| Q3 24 | 9.8% | -131.2% | ||
| Q2 24 | 6.1% | -110.9% | ||
| Q1 24 | 6.7% | -544.4% |
| Q4 25 | $0.76 | $-0.73 | ||
| Q3 25 | $0.41 | $-0.82 | ||
| Q2 25 | $0.74 | $-0.75 | ||
| Q1 25 | $1.34 | $-0.81 | ||
| Q4 24 | $0.62 | $-0.71 | ||
| Q3 24 | $0.63 | $-0.73 | ||
| Q2 24 | $0.40 | $-0.55 | ||
| Q1 24 | $0.45 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $254.8M | $139.1M |
| Total Assets | $1.3B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $388.9M | ||
| Q3 25 | $1.2M | $416.1M | ||
| Q2 25 | $1.4M | $291.0M | ||
| Q1 25 | $4.6M | $314.5M | ||
| Q4 24 | $1.2M | $320.6M | ||
| Q3 24 | $1.3M | $298.4M | ||
| Q2 24 | $1.5M | $319.1M | ||
| Q1 24 | $1.7M | $201.2M |
| Q4 25 | $254.8M | $139.1M | ||
| Q3 25 | $242.1M | $148.8M | ||
| Q2 25 | $235.4M | $-11.9M | ||
| Q1 25 | $223.1M | $18.9M | ||
| Q4 24 | $208.6M | $21.7M | ||
| Q3 24 | $198.1M | $11.2M | ||
| Q2 24 | $187.9M | $39.3M | ||
| Q1 24 | $179.6M | $61.6M |
| Q4 25 | $1.3B | $480.2M | ||
| Q3 25 | $1.3B | $506.9M | ||
| Q2 25 | $1.3B | $372.7M | ||
| Q1 25 | $1.3B | $386.7M | ||
| Q4 24 | $1.3B | $392.3M | ||
| Q3 24 | $1.3B | $363.6M | ||
| Q2 24 | $1.3B | $381.8M | ||
| Q1 24 | $1.3B | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.1M | $-25.4M |
| Free Cash FlowOCF − Capex | $6.2M | — |
| FCF MarginFCF / Revenue | 5.9% | — |
| Capex IntensityCapex / Revenue | 7.5% | — |
| Cash ConversionOCF / Net Profit | 1.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.1M | $-25.4M | ||
| Q3 25 | $24.7M | $-26.6M | ||
| Q2 25 | $8.1M | $-23.3M | ||
| Q1 25 | $13.8M | $-40.4M | ||
| Q4 24 | $9.3M | $-18.8M | ||
| Q3 24 | $20.9M | $-25.2M | ||
| Q2 24 | $2.2M | $-29.1M | ||
| Q1 24 | $19.7M | $-40.7M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $5.2M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $16.2M | — |
| Q4 25 | 5.9% | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 16.1% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | 15.6% | — |
| Q4 25 | 7.5% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 3.76× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 2.83× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
RYTM
Segment breakdown not available.
